In this video:
Dr Sandeep Arora, Professor & Dean, Faculty of Pharmaceutical Sciences, Amity University
Topic: Biotech and Biosimilars: Chandigarh as Biopharma Hub
Key Takeaway:
With rising global demand and strong domestic capabilities, India is poised to become a major hub for biologics and biosimilars. Strategic investments in R&D, regulatory alignment, and advanced manufacturing can help India tap into this high-value segment